InsidersTradesSigma
Xvivo Perfusion AB Stock: price and management transactions · Finland · FIN-FSA
Follow the Xvivo Perfusion AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Xvivo Perfusion AB has published 1 insider filings. Market capitalisation: €8.9bn. The latest transaction was filed on 4 December 2025 (Purchase). Among the most active insiders: Kristoffer Nordström. Every trade is accessible without an account.
1
Insider Decl.
0
Thresholds
€3,868
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Xvivo Perfusion AB Strong Buy (bullish), based on 5 analysts. Average price target: SEK 337.00.
32Σ signal
Fundamental score
Ranked 15,837 of 25,973 companies
45.1
score / 100
Value32
Quality58
FCF yld-1.9%
Earn yld0.3%
EV/EBITDA·
ROE3.5%
Gross mgn74%
Net mgn3.1%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 4 December 2025
Declarations1 total
250 shares@ €15.47320.0000% mcap100.0% of flowAktieFI:A003U403-1
Ideal exit: 30 Aug 2026 (T+270)
1 of 1 declaration